Gefitinib Tablet, Coated
Product Images NDC 67184-0531

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Gefitinib (NDC 67184-0531). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qilu Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula For Gefitinib (Image 01)

Structural Formula For Gefitinib (Image 01)
Chemical structure of Gefitinib, depicting its molecular arrangement including a fluorophenyl group, chloro substituent, and morpholine ring, consistent with the active ingredient in Gefitinib tablets.*
FDA Label Image

Gefitinib Tablets 250mg (30 tablets count bottle label)

Gefitinib Tablets 250mg (30 tablets count bottle label)
Gefitinib Tablets 250 mg coated tablets label from Qilu Pharmaceutical Co., Ltd. The label includes dosage strength (250 mg), quantity (30 tablets), NDC number (67184-0531-1), and storage instructions. It also displays a barcode and warnings about keeping the medication out of reach of children and storing at controlled room temperature.*
FDA Label Image

Gefitinib Tablets 250mg (500 tablets count bottle label)

Gefitinib Tablets 250mg (500 tablets count bottle label)
Label for Gefitinib Tablets 250 mg, oral coated tablets, provided in a package containing 500 tablets. The label includes the NDC 67184-0531-2 and states it is for prescription use only. Manufactured by Qilu Pharmaceutical Co., Ltd. in Haikou, China.*
FDA Label Image

Gefitinib Tablets 250mg (30 tablets count blister label)

Gefitinib Tablets 250mg (30 tablets count blister label)
Gefitinib Tablets 250 mg unit dose packaging label by Qilu Pharmaceutical Co., Ltd. The label indicates 30 tablets in an overwrap, consisting of 3 cards of 10 tablets each. The packaging notes the product is Rx only and not child resistant, for institutional use only. The NDC 67184-0531-3 is displayed along with storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.